Method and system for treatment of internal nasal valves

Abstract

Internal nasal valve involves injecting a biomaterial filler into the internal nasal valve of the patient. The injected biomaterial filler in the internal nasal valve increases an internal nasal valve angle.

1 . A system for non-surgically treating an internal nasal valve of a patient comprising: a control syringe; and a 2-inch, 25 gauge thin-thin wall short bevel needle, wherein the needle comprises: a 10-20 degree bend at the terminal portion of the needle about 0.25 inches from the terminal end; and a hub for fluidly coupling to the control syringe. 
     
     
         2 . The system of  claim 1 , wherein the control syringe is a 1.0 cc control syringe. 
     
     
         3 . The system of  claim 1 , wherein the control syringe is a 0.3 cc control syringe. 
     
     
         4 . The system of  claim 1 , wherein the needle comprises a 15 degree bend at the terminal portion of the needle about 0.25 inches from the terminal end. 
     
     
         5 . The system of  claim 1 , further comprising a straight needle fluidly coupled to a hub, the straight needle capable of fluidly coupling to the 2-inch needle, and the hub capable of fluidly coupling to the control syringe. 
     
     
         6 . The system of  claim 1 , wherein the needle is stainless steel. 
     
     
         7 . The system of  claim 1 , wherein the hub is stainless steel. 
     
     
         8 . The system of claim  12 , wherein the control syringe is pre-loaded with a biomaterial filler. 
     
     
         9 . The system of  claim 8 , wherein the biomaterial filler is a gel cartilage matrix. 
     
     
         10 . The system of  claim 8 , wherein the biomaterial filler is a calcium hydroxylapatite gel.